Synthesis of Prodrugs of Zidovudine

CNU IR > Pharmacy and Science > The 5rh Conference of Channel-bridge Chemistry, Biology and materal Science > Item 310902800/30501

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/30501

Title:	Synthesis of Prodrugs of Zidovudine
Authors:	Xiu-min Wang Li-juan Wang Wen-fang Zhu Xiao Zheng Jing Li Yanyan Liu
Contributors:	Department of Pharmaceutical Science, Medical College, Xiamen University School of Pharmacy, Heilongjiang University of Traditional Chinese Medicine
Date:	2008-07
Issue Date:	2017-12-04 15:57:20 (UTC+8)
Abstract:	Intensive efforts to develop new chemotherapeutic agents effective against the human immunodeficiency virus (HIV), the etiological agent of acquired immunodeficiency syndrome (AIDS). Zidovudine (3’-azido-2’3’-dideoxythymidine, AZT, azidothymidine) is the first FDA-approved drug available for the treatment of patients suffering from AIDS and AIDS-related complex. Treatment of AZT has led to a decrease in the mortality rate and frequency of opportunistic infections in AIDS patients. But AZT has three disadvantages or side effects. They are (1) the short plasma half-life (about 1 hour), (2) significant dose-related toxicity (bone marrow toxicity, severe anemia), (3) on ability to penetrate into brain. In attempts to overcome the problem of rapid elimination and decreased permeability of AZT through the blood brain barrier and to increase its therapeutic efficacy, we have synthesized a variety of 5’-ester of AZT. Here we synthesize the 5’-arachidate of AZT for the first time. The synthesis of prodrugs of zidovudine was showed in Scheme 1. The further study on biological evaluation and pharmaceutical research of these compounds are carrying on.
Relation:	第五屆海峽化學、生物及材料研討會，起迄日：2008/07/21-2008/07/22，地點：嘉南藥理科技大學
Appears in Collections:	[Pharmacy and Science] The 5rh Conference of Channel-bridge Chemistry, Biology and materal Science

Files in This Item:

File	Description	Size	Format
C21.pdf		342Kb	Adobe PDF	289	View/Open

Loading...